Previous Article | Next Article ![]()
Infection and Immunity, May 2001, p. 3264-3270, Vol. 69, No. 5
Departments of
Microbiology1 and
Pathology,2 Colorado State University,
Fort Collins, Colorado 80523
Received 15 September 2000/Returned for modification 13 December
2000/Accepted 9 February 2001
In this study different inbred strains of mice appeared to control
and contain a low dose aerosol infection with Mycobacterium tuberculosis in a similar manner, giving rise to a chronic state of disease. Thereafter, however, certain strains gradually began to
show evidence of regrowth of the infection, whereas others consistently
did not. Using C57BL/6 mice as an example of a resistant strain and
CBA/J mice as an example of a strain susceptible to bacterial growth,
we found that these animals revealed distinct differences in the
cellular makeup of lung granulomas. The CBA/J mice exhibited a
generally poor lymphocyte response within the lungs and vastly
increased degenerative pathology at a time associated with regrowth of
the infection. As a possible explanation for these events, it was then
observed that the CBA/J mouse strain was also less able to upregulate
adhesion molecules, including CD11a and CD54, on circulating
lymphocytes. These results therefore suggest that a failure to control
a chronic infection with M. tuberculosis may reflect an
inability to localize antigen-specific lymphocytes within the lung.
Disease caused by
Mycobacterium tuberculosis is often not due to primary
infection but instead is caused by reactivation of a latent or dormant
infection that the patient may have carried for many years
(20). It is unclear however, how the host initially expresses resistance in the lung and why this resistance is eventually lost, thus allowing bacterial regrowth. In this regard, the mouse is a
useful model of specific resistance to M. tuberculosis
infection. After low or moderate doses of bacilli are delivered by
either intravenous or aerogenic routes, an apparently stable chronic disease state is established after a few weeks in the infected organs
of the animal (3, 24). This chronic infection continues for a prolonged period in the C57BL/6 mouse strain until influenced by
immunosenescence (23). It is currently speculated that
during the chronic phase of infection, the bacteria remain in some form of latent state.
That this assumption may be wrong, however, is suggested by recent
evidence indicating that chronic M. tuberculosis infection in the lung is in fact a dynamic event (27), at least in
terms of granuloma pathology, which changes dramatically over the life span of the animal. In addition, studies directed toward understanding the role of the Bcg gene (Nramp1) have shown that
certain inbred strains of mice clearly differ in their ability to
survive a chronic M. tuberculosis infection (16,
18), in confirmation of much earlier reports of this phenomenon
(15, 26).
The results of the current study confirm and extend these findings by
showing that certain strains of mice, although able to initially
control a low-dose aerosol infection with M. tuberculosis, eventually succumb during the chronic phase of disease. The current study shows that this early mortality was associated with an increased bacterial burden within the lung and occurred prior to events that
could be attributed to immunosenesence (23). Comparison of
the pathology in reactivation-prone mice and those which were able to
maintain the chronic disease state highlighted profound differences as
early as the first few weeks into infection. Of these, the most obvious
difference was the predominance of macrophages, combined with a minimal
lymphocyte influx, within the lesions of the susceptible mouse strains.
This absence of lymphocytes was associated with a failure to upregulate
the T-cell adhesion molecules CD11a and CD54 on circulating
lymphocytes. These data thus imply that strains of mice prone to this
regrowth or reactivation phenomenon are less able to recruit
lymphocytes to the site of infection and that this inability then
predisposes the animal to an increased likelihood of bacterial regrowth
at a later time.
Mice.
These studies were performed using
specific-pathogen-free C57BL/6, DBA/2, or CBA/J female mice (Jackson
Laboratories, Bar Harbor, Maine) at 6 to 8 weeks of age. Mice were kept
in ABL-3 biohazard conditions throughout the study and maintained on
sterile chow and water ad libitum. The specific-pathogen-free nature of the mouse colonies was demonstrated by testing sentinel animals. These
were shown to be negative for 12 known mouse pathogens.
Bacteria.
M. tuberculosis strains Erdman, H37Rv,
and CSU22 were grown from low-passage seed lots in Proskauer-Beck
liquid media containing 0.02% Tween 80 to mid-log phase and then
separated into aliquots and frozen at Bacterial infections.
Mice were infected via the aerosol
route with a low dose (102) or a high dose
(103) of bacteria. Briefly, the nebulizer compartment of a
Middlebrook airborne infection apparatus (Glas-col, Terre Haute, Ind.)
was filled with 5 ml of distilled water containing a suspension of bacteria known to deliver approximately 100 or 1,000 bacteria per lung.
Enumeration of bacteria.
The numbers of viable bacteria in
the lungs were monitored over time by plating serial dilutions of
individual whole-organ homogenates onto nutrient Middlebrook 7H11 agar
and counting the bacterial colony formations after 21 days incubation
at 37°C. The data was expressed as the log10 value of the
mean number of bacteria recovered (n = 4 animals).
Estimation of mouse morbidity.
Infected mice were monitored
regularly, and those exhibiting signs of recrudescent disease were
euthanized. Markers for poor health were loss of weight, poor coat
condition, and lethargy.
Histology.
The lower right lung lobe from each mouse was
inflated with 10% formal saline. Tissues were prepared routinely and
sectioned for light microscopy with lobe orientation designed to allow
for the maximum surface area of each lobe to be seen. Consecutive sections were stained with hematoxylin and eosin or with Ziehl-Neelsen stain for the detection of acid-fast bacilli. Sections were examined by
a veterinary pathologist without prior knowledge of the experimental groups and evaluated at least twice to verify the reproducibility of
the observations.
Flow cytometry.
A single cell suspension was prepared from
spleens as described previously (9). Cells from each
individual mouse were incubated with specific antibody (fluorescein
isothiocyanate [FITC], phycoerythrin [PE], PerCP, or
allophycocyanin [APC] labeled at 25 µg/ml) for 30 min at 4°C and
in the dark. After two washes in D-RPMI lacking biotin and phenol red
(Irvine Scientific), cells were washed three times prior to analysis on
a Becton Dickinson FACSCalibur. Lymphocytes were gated by forward and
side scatter, and CD4+ and CD8+ T cells were
characterized by the presence of specific fluorescence labeled
antibody. Cell surface markers analyzed were FITC-labeled CD3 Bone marrow-derived macrophage cultures.
Bone marrow-derived
macrophages were prepared 1 week prior to use. Mice were sacrificed,
and the femurs and tibias were removed by dislocation from the joint
and extraction using forceps and dissection scissors. The bones were
placed into Dulbecco modified Eagle medium (DMEM) supplemented with
10% heat-inactivated fetal calf serum, 10% L-929 fibroblast
conditioned supernatant, 1% HEPES buffer (1 M; Sigma), 1%
L-glutamine (200 nM; Sigma), and 2% Minimal essential
medium-nonessential amino acids (100×; Sigma). The femurs were sheared
at the proximal end and flushed with 5 ml of the supplemented media
(S-DMEM). The tibias were snipped above the ankle joint, sheared in a
similar manner to the femur at the proximal end, and flushed with 5 ml
of S-DMEM. The suspension was centrifuged, and the pellets were
resuspended in S-DMEM. Cells were seeded into petri dishes (Corning,
N.Y.) for 6 days before transfer to flat-bottom 96-well tissue culture
plates at a concentration of 2 × 105/well. Wells were
replenished with S-DMEM every 48 h.
CD4 overlay assays.
One day before the CD4 T-cell
purification, the S-DMEM medium was replaced with medium lacking L-929,
and the macrophages were pulsed with culture filtrate proteins (CFP)
(10 µg/ml) (supplied by J. Belisle [under NIH contract AI-75320],
Department of Microbiology, Colorado State University) or ovalbumin (10 µg/ml). The following day the spleens were harvested from infected
mice and gently dispersed through a mesh sieve. Red blood cells were
lysed using Geys lysis buffer and resuspended in phosphate-buffered
saline plus 2.5% bovine serum albumin. Cells were incubated with
anti-CD4 microbeads for 15 min (Miltenyi Biotec, Auburn, Calif.). CD4 T
cells were purified using a magnetic column (Miltenyi Biotec) and
resuspended at 106 cells/ml in DMEM (Sigma, St. Louis, Mo.)
plus supplements. Pure CD4 T cells (>95% pure, assessed by flow
cytometry) were overlaid onto macrophages prepulsed with antigen.
Cultures were incubated for 72 h at 37°C, 5% CO2
prior to cytokine analysis.
IFN- Statistical analysis.
Statistical significance was carried
out using the Student t test and found to be significant
(P < 0.05) or highly significant (P < 0.005).
Increased susceptibility to tuberculosis is characterized by a
regrowth of bacteria in the lung.
As previously described
(16, 18), mouse strains differ in their susceptibility to
M. tuberculosis, even in the aerosol model
(17). By comparing the progression of aerosol infection between C57BL/6, DBA/2, and CBA/J mice, we were able to confirm these
observations by detecting increased bacterial numbers in the lungs of
the recrudescence-susceptible CBA/J and DBA/2 strains (Fig.
1). This increase in numbers correlated
with decreased survival (mean survival time from high-dose
[103] aerosol infection with M. tuberculosis
Erdman; C57BL/6, 345 ± 23 days; CBA/J, 232 ± 26 days; and DBA/2,
186 ± 23 days). Increased bacterial numbers within the lungs of
CBA/J and DBA/2 mice was also highly reproducible for other strains of
M. tuberculosis (Fig. 1). Interestingly, the CBA/J and DBA/2
mouse strains were clearly able to stabilize the infection within the
lung for at least 60 days, although often at a higher bacterial load.
These mice were unable to maintain the chronic infection, however, and eventually succumbed. Hereafter, C57BL/6 and CBA/J mice are documented as representative examples.
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.5.3264-3270.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Immunological Basis for Reactivation of
Tuberculosis in Mice

![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
70°C until use.
(clone
145-2C11), CD11a (clone 2D7), or CD54 (clone 3E2); PE-labeled CD3
(clone 145-2C11); PerCP-labeled CD8 (clone 53-6.7); and APC-labeled CD4
(clone RM4-5). Appropriate isotype control antibodies were included in
each analysis. All antibodies were purchased from Pharmingen (San
Diego, Calif.). Data were analyzed using CellQuest (Becton Dickinson,
San Diego, Calif.).
ELISA.
Supernatants were harvested from CD4 T cell
overlay cultures and assayed for the presence of gamma interferon
(IFN-
) by enzyme-linked immunosorbent assay (ELISA). Antibodies were
purchased from Pharmingen. Briefly, the primary antibody (Pharmingen
clone R4-6A2) was incubated overnight in 96-well round-bottom Immulon 2 plates in carbonated coating buffer. Excess antibody was washed away
using PBS-Tween 20 (PBS-T). The wells were blocked with 3% bovine
serum albumin in PBS-T. The samples were dispensed, in duplicate, into
the wells. A standard curve for IFN-
(Genzyme) was prepared for each
individual plate. Cytokine production was detected by the addition of a
secondary biotinylated antibody (Pharmingen clone XMG1.2), followed by
avidin-peroxidase (Zymed Labs, Inc., San Francisco, Calif.) and TMB
substrate (Dako, Carpinteria, Calif.).
![]()
RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

View larger version (14K):
[in a new window]
FIG. 1.
Growth of M. tuberculosis in C57BL/6, DBA/2,
and CBA/J mouse strains. C57BL/6 (
), CBA/J (
), and DBA/2 (
)
mice were aerogenically infected with M. tuberculosis
Erdman, H37Rv, or CSU22. The bacterial load was calculated by plating
partial organ homogenate onto 7H11 agar and counting colonies after 21 days at 37°C. The infective dose was calculated by plating lung
homogenate 1 day after infection. The data are expressed as the
mean ± the standard error of the mean from four mice per group.
The graphs are representative of five (Erdman), two (CSU22), or two
(H37Rv) independent experiments.
Progression of lung pathology in different mouse strains.
Examination of the lungs of the different mouse strains given a
low-dose aerosol infection with M. tuberculosis Erdman
revealed dramatic differences in the development and degeneration of
the granulomatous response. In C57BL/6 mice, the lung lesions developed as we have previously described in detail (27). Briefly,
moderately sized lesions were observed over the first 3 to 4 weeks
after infection. The lesions consisted predominantly of macrophages. Some lymphocytes could be seen associated with these lesions, although
most were perivascular. By day 60 (Fig.
2A), these perivascular cuffs were
prominent, and large aggregates of lymphocytes were seen within the
epithelioid macrophage fields. The development of organized multifocal
granulomas containing lymphocytes and macrophages progressed through
days 150 (Fig. 2B) and 295 (Fig. 2C).
|
Circulating CD4 T lymphocytes from CBA/J mice can respond to CFP
from M. tuberculosis.
The absence of lymphocyte foci
within the lung lesions of CBA/J mice could have been a consequence of
an inability of these mice to mount a strong antigen-specific T-cell
response. To address this point, we purified CD4+ T cells
from the splenic cell population and cultured them with CFP from
M. tuberculosis. The purified CD4+ T cells from
both the C57BL/6 and CBA/J mouse strains were capable of generating an
IFN-
response against macrophages pulsed with CFP throughout the
course of the experiment (Table 1).
Responses to ovalbumin throughout the experiment were equivalent to
uninfected control data (not shown).
|
The expression of T-cell homing molecules is reduced on circulating
lymphocytes from CBA/J mice.
To assess whether the circulating
lymphocytes were capable of expressing the adhesion molecules
associated with cellular migration to inflammatory sites, we analyzed
splenic T cells from the different mouse strains for the upregulation
of several adhesion molecules (Fig. 3).
The most striking difference throughout the first 35 days of infection
was the observation that circulating lymphocytes from the C57BL/6 mice
expressed increasing levels of the adhesion molecule CD11a on their
circulating CD4+ (Fig. 3A) and CD8+ (Fig. 3B) T
cells. This shift to CD11abright expression was absent
on the circulating T cells from CBA/J mice. In addition, lymphocytes
from C57BL/6 mice demonstrated brighter expression of ICAM-1 (CD54) on
both the CD4+ T cells (3C) and the CD8+ T cells
(3D) than did the lymphocytes from CBA/J mice.
|
| |
DISCUSSION |
|---|
|
|
|---|
This study confirms and extends the findings of Medina and North (16, 18), who demonstrated that several mouse strains were more susceptible to M. tuberculosis infection than other mouse strains. As shown here, CBA/J and DBA/2 mice were able to control an aerosol infection, initially leading to a chronic disease state indistinguishable from that seen in the C57BL/6 mice. However, by about 60 days postinfection the bacterial load began to increase, a result which was associated with higher mortality rates in these mouse strains.
The development of disease in susceptible mouse strains was
characterized by lung lesions consisting predominantly of macrophages and a few lymphocyte aggregates. As the infection progressed and the
bacterial load increased, the lesions became degenerative, with
evidence of macrophage breakdown and an influx of neutrophils. The data
obtained support the hypothesis that the failure to adequately recruit
lymphocytes into the infected lung was not due to a lack of
antigen-specific immunity but instead was potentially associated with a
failure to upregulate adhesion molecules that are associated with
cellular localization of T cells to inflammatory sites (28, 29). Irregardless of whether lymphocytes were capable of
producing IFN-
in response to antigen, the failure to focus
lymphocytes within infected tissue would compromise the ability to
directly deliver this cytokine to its target.
Human genetic studies (10, 30) and the strikingly disparate results obtained from BCG vaccination trials (5, 6, 31) suggest that genetic linkage with susceptibility to M. tuberculosis infection may be an important issue. A recent study in Africa has identified markers on chromosomes 15q and Xq (2), which supports the hypothesis that susceptibility to M. tuberculosis is multifactoral in nature. What is clear from these studies is that it is extremely difficult to highlight one specific genetic trait which confers susceptibility to tuberculosis. Therefore, the importance of identifying biological correlates of protection is paramount in the identification of infected individuals who will later go on to develop reactivation disease.
In this study we demonstrate that the CBA/J mouse strain, despite evidence that it possessed the capacity to generate antigen-specific T lymphocytes, failed to upregulate the expression of two adhesion molecules, CD11a (LFA-1 component) and CD54 (ICAM-1), on the surface of circulating T lymphocytes. The inability to alter the expression of these two molecules was apparent on both the CD4+ and the CD8+ T-cell populations, which would clearly effect the ability of T lymphocytes to enter the lung. Indeed, the isolation of small numbers of cells from the infected lung shows that even CD4+ T cells from the lungs of CBA/J mice had significantly lower CD11a expression than similar cells isolated from the C57BL/6 mouse strain (unpublished observations).
The importance of interactions between adhesion molecules during
M. tuberculosis infection has been highlighted recently in a
study which demonstrated that blocking of the
4 integrin
led to a reduction in lymphocyte-dominated lesions within the lung and
the development of granulocyte-dominated lesions (4). The
4
7 integrin has been reported to be
required for the subsequent engagement of LFA-1 (CD11a) and rolling of
lymphocytes across HEV (1), and therefore the lack of
4
integrin interactions may also influence upstream events in the
recruitment of lymphocytes into inflammatory sites. ICAM-1 is also
upregulated on the epithelium and endothelium of cells infected with
other bacteria (7, 12), thus suggesting a role for this
molecule in cellular localization around infected tissue.
That differences in CD11a and CD54 expression could be a downstream event in CBA/J and DBA/2 mice needs to be addressed. The upregulation of these molecules is dependent on the responsiveness to inflammatory chemokines such as tumor necrosis factor or MCP-1 (8, 25). Chemokine mRNA within the lungs of infected C57BL/6 and CBA/J mice was equivalent (unpublished observations); however, we cannot as yet rule out the possibility that CBA/J and DBA/2 mice have deficiencies in the expression of chemokine receptors. A deficiency in C5a, another inflammatory mediator, has recently been reported in the A/J mouse strain (11), and C5 deficiency has been linked to susceptibility to infection with M. tuberculosis (11). Further studies will need to be carried out to address whether C5a deficiency is responsible for the susceptibility to M. tuberculosis seen in the CBA/J mouse or, indeed, in humans.
Different mouse strains have been used extensively in studies of M. tuberculosis immunity, the majority of which have demonstrated that several strains are indeed more susceptible to M. tuberculosis than others (15, 18, 21, 26). Our results are in keeping with those of Medina and North, who demonstrated that, after a low-dose infection with M. tuberculosis, all susceptible mouse strains survived for only 80 days after intravenous infection and for 120 days after aerosol infection (18). Examination of lung lesions showed that the DBA/2 mouse strain had bigger lesions consisting of more foamy epithelioid macrophages, as we also demonstrate in more detail here with the CBA/J mouse (16). In contrast, recent studies by Nikonenko et al. have shown that the I/St and A/Sn mouse strains express different susceptibility phenotypes much earlier (21). Although these two genetically similar strains are useful for identifying particular genetic determinants, the M. tuberculosis inoculum used was very high and the survival time was extremely reduced even in the resistant strain. High doses of M. tuberculosis administered into the lung will induce severe inflammation, and therefore this is not a useful model for the control of chronic M. tuberculosis infection.
The genetic determinants of resistance to M. tuberculosis have been long sought after, and these susceptible mouse models have been useful tools in aiding this search. Despite the obvious coassociation of Nramp1 expression in the susceptible mouse strains (18), it has been clearly demonstrated that Nramp1 alone is not able to confer an M. tuberculosis-resistant phenotype to a naturally susceptible strain (17, 19, 22). The resistant phenotype is evidently dominant (17, 18) and has been suggested to have H-2 linkages in the mouse, although non-major-histocompatibility-complex genes seem to also play a major role (18). The susceptible phenotype thus appears to be multifactoral in nature.
In support of this hypothesis, recent evidence has identified several gene linkages associated with susceptibility in the mouse, including genes associated with weight loss and short survival time on chromosomes 9 and 3 of the I/St mouse strain (14). In studies using the C57BL/6 and C3HeB/FeJ mouse strains, susceptibility has also been associated with a 9-centimorgan interval on mouse chromosome 1 named sst1 (13), which is located close to but not including the Nramp1 site and which confers some degree of resistance to pulmonary tuberculosis. Whether this gene plays a role in other M. tuberculosis- susceptible mouse strains has yet to be addressed. What is certain is that these single genes alone are not able to confer susceptibility.
In conclusion, we have demonstrated that the CBA/J mouse strain, previously characterized as susceptible to M. tuberculosis infection (18), develops lung lesions consisting predominantly of macrophages. The absence of lymphocytic infiltration was associated with a failure to upregulate CD11a and CD54 molecules on the surface of the T lymphocytes, therefore compromising the ability of these cells to migrate to inflammatory sites and focus into distinct lesions normally observed in the resistant C57BL/6 mouse strain. Therefore, the upregulation of CD11a and CD54 in response to M. tuberculosis challenge may be a useful correlate of protection and resistance to reactivation diseases which could be tested in the field.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by NIH grants AI-44072, AI-40488, and AG-06946.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Microbiology, Colorado State University, Fort Collins, CO 80523. Phone: (970) 491-6127. Fax: (970) 491-1815. E-mail: Jturner{at}cvmbs.colostate.edu.
Present address: Centenary Institute, Newtown, NSW 2042, Australia.
Editor: V. J. DiRita
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Bargatze, R. F., M. A. Jutila, and E. C. Butcher. 1995. Distinct roles of L-selectin and integrins alpha 4 beta 7 and LFA-1 in lymphocyte homing to Peyer's patch-HEV in situ: the multistep model confirmed and refined. Immunity 3:99-108[CrossRef][Medline]. |
| 2. |
Bellamy, R.,
N. Beyers,
K. P. W. J. McAdam,
C. Ruwende,
R. Gie,
P. Samaai,
D. Bester,
M. Meyer,
T. Corrah,
M. Collin,
D. R. Camidge,
D. Wilkinson,
E. H.-V. Helden,
H. C. Whittle,
W. Amos,
P. V. Helden, and A. V. S. Hill.
2000.
Genetic susceptibility to tuberculosis in Africans: a genome-wide scan.
Proc. Natl. Acad. Sci. USA
97:8005-8009 |
| 3. | Cardona, P. J., A. Cooper, M. Luquin, A. Ariza, F. Filipo, I. M. Orme, and V. Ausina. 1999. The intravenous model of murine tuberculosis is less pathogenic than the aerogenic model owing to a more rapid induction of systemic immunity. Scand. J. Immunol. 49:362-366[CrossRef][Medline]. |
| 4. |
Feng, C. G.,
W. J. Britton,
U. Palendira,
N. L. Groat,
H. Briscoe, and A. G. D. Bean.
2000.
Up-regulation of VCAM-1 and differential expansion of integrin-expressing T lymphocytes are associated with immunity to pulmonary Mycobacterium tuberculosis infection.
J. Immunol.
164:4853-4860 |
| 5. | Fine, P. E. M. 1994. Immunities in and to tuberculosis: implications for pathogenesis and vaccination, p. 53-71. In J. D. H. Porter, and K. P. W. J. McAdam (ed.), Tuberculosis: back to the future. John Wiley & Sons, Ltd., London, England. |
| 6. | Fine, P. E. M., and D. Clayton. 1996. Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Lancet 348:17-24[CrossRef][Medline]. |
| 7. |
Frick, A. G.,
T. D. Joseph,
L. Pang,
A. M. Rabe,
R. J. W. St. Geme, and D. C. Look.
2000.
Haemophilus influenzae stimulates ICAM-1 expression on respiratory epithelial cells.
J. Immunol.
164:4185-4196 |
| 8. | Gonzalez-Amaro, R., and F. Sanchez-Madrid. 1999. Cell adhesion molecules: selectins and integrins. Crit. Rev. Immunol. 19:389-429[Medline]. |
| 9. |
Griffin, J. P., and I. M. Orme.
1994.
Evolution of CD4 T-cell subsets following infection of naive and memory immune mice with Mycobacterium tuberculosis.
Infect. Immun.
62:1683-1690 |
| 10. | Hill, A. V. 1998. The immunogenetics of human infectious diseases. Annu. Rev. Immunol. 16:593-617[CrossRef][Medline]. |
| 11. | Jagannath, C., H. Hoffman, E. Sepulveda, J. K. Actor, R. A. Wetsel, and R. L. Hunter. 2000. Hypersusceptibility of A/J mice to tuberculosis is in part due to a deficiency of the fifth complement component. Scand. J. Immunol. 52:369-379[CrossRef][Medline]. |
| 12. |
Jarvis, G. A.,
J. Li, and K. V. Swanson.
1999.
Invasion of human mucosal epithelial cells by Neisseria gonorrhoeae upregulates expression of intercellular adhesion molecule 1 (ICAM-1).
Infect. Immun.
67:1149-1156 |
| 13. |
Kramnik, I.,
W. F. Dietrich,
P. Demant, and B. R. Bloom.
2000.
Genetic control of resistance to experimental infection with virulent Mycobacterium tuberculosis.
Proc. Natl. Acad. Sci. USA
97:8560-8565 |
| 14. | Lavebratt, C., A. S. Apt, B. V. Nikonenko, M. Schalling, and E. Schurr. 1999. Severity of tuberculosis in mice is linked to distal chromosome 3 and proximal chromosome 9. J. Infect. Dis. 180:150-155[CrossRef][Medline]. |
| 15. | Lynch, C. J., C. H. Pierce-Chase, and R. Dubos. 1965. A genetic study of susceptibility to experimental tuberculosis in mice infected with mammalian tubercle bacilli. J. Exp. Med. 121:1051-1069[Abstract]. |
| 16. | Medina, E., and J. North. 1999. Genetically susceptible mice remain proportionally more susceptible to tuberculosis after vaccination. Immunology 96:16-21[CrossRef][Medline]. |
| 17. |
Medina, E., and R. J. North.
1996.
Evidence inconsistent with a role for the Bcg gene (Nramp1) in resistance of mice to infection with virulent Mycobacterium tuberculosis.
J. Exp. Med.
183:1045-1051 |
| 18. | Medina, E., and R. J. North. 1998. Resistance ranking of some common inbred mouse strains to Mycobacterium tuberculosis and relationship to major histocompatibility complex haplotype and Nramp1 genotype. Immunology 93:270-274[CrossRef][Medline]. |
| 19. | Medina, E., B. J. Rogerson, and R. J. North. 1996. The Nramp1 antimicrobial resistance gene segregates independently of resistance to virulent Mycobacterium tuberculosis. Immunology 88:479-481[CrossRef][Medline]. |
| 20. | Murray, C. J. L., K. Styblo, and A. Rouillon. 1990. Tuberculosis in developing countries: burden, intervention and cost. Bull. Int. Union Tuberc. Lung Dis. 65:6-24[Medline]. |
| 21. | Nikonenko, B. V., J. M M Averbakh, C. Lavebratt, E. Schurr, and A. S. Apt. 2000. Comparative analysis of mycobacterial infections in susceptible I/St and resistant A/Sn inbred mice. Tuberc. Lung Dis. 80:15-25[CrossRef][Medline]. |
| 22. |
North, R. J.,
R. LaCourse,
L. Ryan, and P. Gros.
1999.
Consequence of Nramp1 deletion to Mycobacterium tuberculosis infection in mice.
Infect. Immun.
67:5811-5814 |
| 23. | Orme, I. M. 1987. Aging and immunity to tuberculosis: increased susceptibility of old mice reflects a decreased capacity to generate mediator T lymphocytes. J. Immunol. 138:4414-4418[Abstract]. |
| 24. | Orme, I. M. 1987. The kinetics of emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacterium tuberculosis. J. Immunol. 138:293-298[Abstract]. |
| 25. | Petruzzelli, L., M. Takami, and H. D. Humes. 1999. Structure and function of cell adhesion molecules. Am. J. Med. 106:467-476[CrossRef][Medline]. |
| 26. | Pierce, C., R. J. Dubos, and G. Middlebrook. 1947. Infection of mice with mammalian tubercle bacilli grown in Tween-albumin liquid medium. J. Exp. Med. 86:159-175[Abstract]. |
| 27. | Rhoades, E. R., A. A. Frank, and I. M. Orme. 1997. Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis. Tuberc. Lung Dis. 78:57-66[CrossRef][Medline]. |
| 28. | Springer, T. A. 1990. Adhesion receptors of the immune system. Nature 346:425-434[CrossRef][Medline]. |
| 29. | Springer, T. A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration. Cell 76:301-314[CrossRef][Medline]. |
| 30. | Stead, W. W., J. W. Senner, W. T. Reddick, and J. P. Lofgren. 1990. Racial differences in susceptibilities to infection by Mycobacterium tuberculosis. N. Engl. J. Med. 322:422-427[Abstract]. |
| 31. | Tripathy, S. P. 1987. Fifteen year follow-up of the Indian BCG prevention trial. Bull. Int. Union Tuberc. Lung Dis. 62:69-72. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|